Adalimumab - GP2017 ( DrugBank: Adalimumab )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ1

46. 悪性関節リウマチ


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02744755
(ClinicalTrials.gov)
March 31, 201612/4/2016Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid ArthritisA Randomized, Double-blind, Parallel-group, Multicenter Study to Demonstrate Similar Efficacy and to Compare Safety and Immunogenicity of GP2017 and Humira® in Patients With Moderate to Severe Active Rheumatoid ArthritisRheumatoid ArthritisBiological: Adalimumab - GP2017;Biological: Adalimumab - US licensed HumiraSandozHexal AGCompleted18 YearsN/AAll353Phase 3United States;Czechia;Germany;Hungary;Italy;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;United Kingdom;Czech Republic